The Patent Finder

Terms ending in 2035

Baxalta Incorporated

Every in-force patent on Baxalta Incorporated's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,851,481Treatment of Central Nervous System Disorders by Intranasal Administration of Immunoglobulin G
In force
 · Medium confidence
Baxter International Inc. and Baxter Healthcare S.A.In forceMedium confidence
US 9,447,147Peptides and Methods of Use
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 10,124,033Peptides and Methods of Use
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US D878,763Carrying Case
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 10,632,252Subcutaneous Infusion Device for Injecting Medicinal Substances
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US D881,577Carrying Case
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US D886,611Container Unit
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US D890,358Container Unit
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US D893,046Container Unit
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 9,873,892Production of Fully Processed and Functional Factor X in a Furin-Secreting Mammalian Expression System
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
6 more term ends in 2035 · Pro
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
Upgrade to Pro
2 of these are in force and held by Baxalta Incorporated.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited